Reunion Neuroscience Inc. Common Shares
REUN
REUN was delisted on the 31st of July, 2023.
24 hedge funds and large institutions have $35.6M invested in Reunion Neuroscience Inc. Common Shares in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
2,182% more call options, than puts
Call options by funds: $1.62M | Put options by funds: $71K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$18M |
| 2 |
O
OrbiMed
New York
|
+$7.74M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.98M |
| 4 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$3.05M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.72M |
Top Sellers
REUN Hedge Fund Activity: Q3 2021 in Review
24 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Reunion Neuroscience Inc. Common Shares (REUN) for Q3 2021, worth a combined $35.6M.
Buyers outnumbered sellers: 24 funds opened new REUN positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Avidity Partners Management, opening a new position worth an estimated $18M.
- 24 institutional investors held Reunion Neuroscience Inc. Common Shares (REUN) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $35.6M of Reunion Neuroscience Inc. Common Shares stock for Q3 2021.
- 24 funds opened new Reunion Neuroscience Inc. Common Shares positions in Q3 2021 and 0 closed out, a net change of +24 holders.
- The largest Reunion Neuroscience Inc. Common Shares buyer in Q3 2021 was Avidity Partners Management, an estimated $18M added.
Based on aggregated 13F filings for Q3 2021.